Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  endothelin B receptor agonist SPI-1620
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: SPI-1620-12-202, NCI-2013-01789, NCT01773785
Start Over